XClose

UCL Therapeutic Innovation Networks

Home
Menu

Funding Opportunities

New funding schemes for early career researchers are available for each of the TINs, to support the generation of pilot data for translational research projects.

The TINs Pilot Data Scheme is highlighted by the TRO in the below video, and also features previous awardees from 2020 who describe how the scheme enabled them to learn crucial skills, generate data & lead to follow-on funding.

MediaCentral Widget Placeholderhttps://mediacentral.ucl.ac.uk/Player/013h1hf8

Case studies of previous awardees:

For all opportunities, shortlisted applicants will be required to deliver a 2-minute pitch of their proposal followed by 10mins Q&A to a panel of academic and industrial members at a Dragon’s Den style event.

  • Who can apply: Postdoctoral Researchers (PDRA) and non-tenured Principal Investigators. 
  • Who cannot apply: PhD students, Research technicians, tenured Principal Investigators, etc. 
  • Training sign-up deadline: 5th October (1st ACCELERATE Bootcamp event taking place on 6th October)
  • Funding application deadline: 24th October 2021 - NOW CLOSED
Cell & Gene Therapy TIN Pilot Data Scheme - Call 2

The Cell & Gene Therapy TIN is now inviting applications for projects with an aim to accelerate the transition from discovery science to the early stages of therapeutic development by providing responsive and flexible funding to support preliminary translational work. 

What we are looking for: Translational projects involving viral and non-viral gene delivery, direct and ex-vivo gene therapy, gene supplementation, gene editing and CAR-T cells. Projects involving monoclonal antibodies, proteins, oligonucleotides therapies, engineered tissues, biomaterials and small molecules are excluded from this call. 

Level of funding: £5-10k 

Duration of funding: 6 months

Application deadline: Sunday 24th October 11:59pm. 

For more information about the scheme and to apply, please download and complete an application form (which also includes associated training opportunities) and return it by 24th October, sending any questions to Cell & Gene Therapy TIN Coordinator Dr Asha Recino

Devices & Diagnostics TIN Pilot Data Scheme - Call 2

The Devices & Diagnostics TIN, working in conjunction with the UCL Institute of Healthcare Engineering is now inviting applications for projects with an aim to accelerate the transition from discovery science to the early stages of therapeutic development by providing responsive and flexible funding to support preliminary translational work. 

What we are looking for: Translational projects involving the development of therapeutic devices, diagnostic devices, screening tests, prognostic biomarkers. Projects involving medicinal products and advanced therapies (e.g. engineered tissues, cellular biomaterials are excluded from this call. 

Level of funding: £5-10k 

Duration of funding: 6 months. 

Application deadline: Sunday 24th October 11:59pm. 

For more information about the scheme and to apply, please download and complete an application form (which also includes associated training opportunities) and return it by 24th October, sending any questions to TRO Portfolio Manager, Helen Cooksley.

Regenerative Medicine TIN Pilot Data Scheme - Call 2

The Regenerative Medicine TIN is now inviting applications for projects with an aim to accelerate the transition from discovery science to the early stages of therapeutic development by providing responsive and flexible funding to support preliminary translational work. 

What we are looking for: Translational projects involving cells, engineered tissues and biomaterials for therapeutic applications. Projects involving viral and non-viral gene delivery, gene therapy, gene editing, CAR-T cells, monoclonal antibodies, proteins, oligonucleotides therapies, small molecules and medical devices are excluded from this call. 

Level of funding: £5-10k 

Duration of funding: 6 months. 

Application deadline: Sunday 24th October 11:59pm. 

For more information about the scheme and to apply, please download and complete an application form (which also includes associated training opportunities) and return it by 24th October, sending any questions to Cell & Gene Therapy TIN Coordinator Dr Asha Recino

Repurposing TIN Pilot Data Scheme - Call 2

The Repurposing TIN is now inviting applications for projects with an aim to accelerate the transition from discovery science to the early stages of therapeutic development by providing responsive and flexible funding to support preliminary translational work. 

What we are looking for: Translational projects involving the use of marketed drugs for novel medical indications. Screening projects aiming at the identification of new potential molecules without a clear and focused repurposing activity are excluded from this call. 

Level of funding: £5-10k 

Duration of funding: 6 months. 

Application deadline: Sunday 24th October 11:59pm. 

For more information about the scheme and to apply, please download and complete an application form (which also includes associated training opportunities) and return it by 24th October, sending any questions to Cell & Gene Therapy TIN Coordinator Dr Asha Recino

Small Molecules TIN Pilot Data Scheme - Call 2

The Small Molecules TIN is now inviting applications for projects with an aim to accelerate the transition from discovery science to the early stages of therapeutic development by providing responsive and flexible funding to support preliminary translational work. 

What we are looking for: Translational drug discovery projects involving the development, optimisation or testing of new small molecules. Projects involving the use of marketed drugs for novel medical indications are excluded from this call. 

Level of funding: £5-10k 

Duration of funding: 6 months. 

Application deadline: Sunday 24th October 11:59pm. 

For more information about the scheme and to apply, please download and complete an application form (which also includes associated training opportunities) and return it by 24th October, sending any questions to TRO Portfolio Manager, Helen Cooksley.